Literature DB >> 5695509

Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study.

E L Saenger, G E Thoma, E A Tompkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5695509

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

1.  Is it really this simple?

Authors:  Martin Charron; Brian C Lentle
Journal:  Pediatr Radiol       Date:  2003-09-16

Review 2.  [Therapy of thyroid gland autonomy].

Authors:  W Becker
Journal:  Klin Wochenschr       Date:  1990-06-19

3.  Treatment of thyrotoxicosis.

Authors:  R S Swerdloff
Journal:  Calif Med       Date:  1970-08

Review 4.  Hyperthyroidism.

Authors:  P Kendall-Taylor
Journal:  Br Med J       Date:  1972-05-06

5.  Benefits and risks in nuclear medicine.

Authors:  P C Johnson
Journal:  Am J Public Health       Date:  1972-12       Impact factor: 9.308

6.  Adult leukemia following diagnostic x-rays? (Review of report by BROSS, BALL, and FALEN on a tri-state leukemia survey).

Authors:  J D Boice; C E Land
Journal:  Am J Public Health       Date:  1979-02       Impact factor: 9.308

7.  [Current controversies in risk-adapted therapy in differentiated thyroid cancer: Is less (therapy) really more?]

Authors:  Amir Kurtaran; Brigitta Schmoll-Hauer; Christina Tugendsam
Journal:  Wien Med Wochenschr       Date:  2019-12-03

8.  Cancer in iodine-131 exposed patients.

Authors:  P Hall; L E Holm
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

9.  Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China.

Authors:  W Zheng; M S Linet; X O Shu; R P Pan; Y T Gao; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

10.  Low-dose 131I in treatment of Graves' disease.

Authors:  C P Lowdell; H J Dobbs; G S Spathis; V R McCready; D O Cosgrove; C L Harmer
Journal:  J R Soc Med       Date:  1985-03       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.